跳至主要内容
临床试验/ACTRN12621000679886
ACTRN12621000679886已完成未知

Intensive long-term rehabilitation for people livingwith chronic spinal cord injury: a feasibility trial

Griffith University0 个研究点目标入组 5 人开始时间: 2021年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion/exclusion criteria for participants have been determined in consultation with medical and
  • rehabilitation specialists including a clinician with a lived experience of SCI.
  • Participants are eligible to be included in the study only if all the following criteria apply:
  • i. Have sustained a traumatic spinal cord injury a minimum of 12 months prior to consent
  • and have completed their primary rehabilitation;
  • ii. Have stable neurological level and functional ability of more than 6 months in duration;
  • iii. Are over 18 years and able to give informed consent;
  • iv. Are ASIA A or B (as per the International Standards for Neurological Classification of
  • v. Are able and willing to attend an exercise program five times per week for 26 (16 weeks 'on-site' and 10 weeks 'at-home') weeks;
  • vi. Are considered by their general practitioner or specialist medical consultant to be fit to
  • undertake the exercise program (documented approval by general practitioner or
  • specialist medical consultant required).

排除标准

  • Participants are excluded from the study if any of the following criteria apply:
  • i. Have significant concomitant central nervous system, peripheral nervous system or
  • musculoskeletal system injuries or disorders limiting ability to exercise;
  • ii. Have had recent major trauma or surgery within the last 6 months;
  • iii. Have an existing stage 3 or 4 pressure ulcer according to the National Pressure Ulcer
  • Advisory Panel classification;
  • iv. Have endocrinopathy or metabolic disorders of the bone, such as Paget’s disease, lytic
  • or renal bone disease, and senile osteoporosis;
  • v. Have a medical history of exposure to medication(s) known to affect mineral or bone
  • metabolism;
  • vi. Have significant impairment or disability, including physical, neurological or
  • psychological impairments, additional to the spinal cord injury;
  • vii. Have a history of long bone fracture incompletely healed;
  • viii. Have extensive fixed contractures in the upper or lower limbs;
  • ix. Have severe spasticity;
  • x. Have uncontrolled neuropathic pain;
  • xi. Have autonomic dysreflexia without a management plan;
  • xii. Are unable to attend the 2-week pre-assessment and the 8-week follow-up
  • assessments;
  • xiii. Have any contraindications to FES such as a cardiac pacemaker, epilepsy, lower limb
  • fracture or pregnancy;
  • xiv. Have any other serious medical condition including malignancies, psychiatric,
  • behavioral or drug dependency problems, which are likely to influence the
  • participant’s ability to cooperate or in the opinion of the study investigator would
  • prevent adherence to the protocol;
  • xv. Have symptomatic, radiologically demonstrated, or provocatively demonstrated
  • ischaemic heart disease;
  • xvi. Have current thromboembolic disease;
  • xvii. Are using illicit drugs;
  • xviii. Are participating in other clinical trials (including medication, therapeutic
  • interventions and alternative therapies) or taking medications (including herbal
  • preparations) that are not considered to be standard care as per the protocol;
  • xix. Are unable to tolerate expected exercise load.

研究者

相似试验